Epcoritamab (Anti-CD20 & CD3)
Product Specifications
CAS Number
2134641-34-0
Synonyms
GEN3013, DuoBody-CD3xCD20
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Epcoritamab is a bispecific IgG1 antibody that targets CD3 and CD20, exhibiting strong T-cell-mediated cytotoxic activity against CD20+ malignant B cells. It is used in the treatment of adults in relapsed or refractory (R/R) large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma after ≥2 lines of systemic treatment. MW: 145.26 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-9249R-BF647 100 µL
RNF123 Polyclonal Antibody, AbBy Fluor™ 647 Conjugated
Sign In for Pricing
View Details 
abx301713-01 20 µg
Cilia-and Flagella-Associated Protein 68 (CFAP68) Antibody
Sign In for Pricing
View Details abx301713-02 50 µg
Cilia-and Flagella-Associated Protein 68 (CFAP68) Antibody
Sign In for Pricing
View Details abx301713-03 100 µg
Cilia-and Flagella-Associated Protein 68 (CFAP68) Antibody
Sign In for Pricing
View Details abx301713-04 200 µg
Cilia-and Flagella-Associated Protein 68 (CFAP68) Antibody
Sign In for Pricing
View Details